LLY: Premium Rides on Obesity Momentum
LLY trades on obesity drug momentum, not its base business. The stock’s 34.5% volatility shows how much rides on every obesity update. One weak quarter, and the rerating could be brutal. For this price, perfection is mandatory.
Published by AssetNext · 2026-06-10
| Date | Signal | Peer score | Drawdown | 21d vs sector |
|---|---|---|---|---|
| 2026-06-09 | Quality confirmed | 70 | -0.4% | +19.4% |
| 2026-05-26 | Quality confirmed | 71 | -3.7% | +23.2% |
| 2026-05-26 | Quality confirmed | 71 | -3.7% | +20.9% |
| 2026-05-19 | Quality confirmed | 71 | -7.7% | +16.8% |
Break down LLY's structural position across all peer dimensions with the interactive app.